SHINVA(SH:600587) Zheng Quan Ri Bao·2025-07-08 15:44Core Viewpoint - Shandong Xinhua Medical Instrument Co., Ltd. has successfully obtained a Class II medical device registration for its thoracic and abdominal endoscope products, enhancing its micro-invasive laparoscopic solution offerings and creating new market growth opportunities [1][2]. Company Summary - The newly approved thoracic and abdominal endoscope is compatible with Xinhua Medical's medical endoscope imaging system and micro-invasive laparoscopic surgical instruments, featuring ultra-clear imaging and high-temperature, high-pressure sterilization capabilities, addressing clinical issues such as image blurriness and inaccurate tissue identification [1]. - The successful registration enriches the variety of Xinhua Medical's micro-invasive laparoscopic surgical products and enhances the company's overall capability in the micro-invasive laparoscopic instrument sector [1]. - In 2024, the company completed the registration of seven new Class II products, including a 4K fluorescence endoscope imaging system and a thoracic and abdominal endoscope, while also developing micro-invasive consumables [2]. Industry Summary - The thoracic and abdominal endoscope market is competitive, and the increase in product variety allows Xinhua Medical to better meet the diverse needs of medical institutions, potentially attracting more customers and expanding market share [2]. - The domestic medical endoscope market is rapidly developing, with the hard endoscope market projected to reach approximately 11 billion yuan in 2024, growing at a compound annual growth rate of 12.46% from 2016 to 2024 [3]. - Recent policy support from the National Medical Products Administration aims to enhance the development of the medical device industry, encouraging companies to increase R&D investment and improve product quality and competitiveness [3].